Form D · Other Health Care
HYPREVENTION INC.
New York, NY · CIK 0002019102
Offering snapshot reported May 1, 2024 · SEC filing
- Reported sold
- $16.1M Offering amount: $16.1M
- Investors reported
- 42 Form D · investor count
- Minimum accepted
- $0 Reported outside-investor minimum
- First sale
- Apr 2, 2024 As reported in this filing
What changed?
Latest filing versus its linked predecessor, where available.
No comparable changes in the displayed metrics.
Filing history
Scroll to see all columns →
| Filed | Filing type | Reported sold | Change vs linked filing | Investors | Source |
|---|---|---|---|---|---|
| May 1, 2024 | Initial | $16,050,913 | No comparison | 42 | SEC filing |
Offering details
- Securities
- Equity, Option to acquire
- Exemptions
- 06b
- Duration over one year
- No
- Business combination
- No
- Sales commissions
- $0
- Finders' fees
- $0
- Form D file number
- 021-512135
Source: Form D, filed May 1, 2024. Minimum accepted may differ from a standard advertised minimum.
Fund connections
No confirmed ADV fund connection is available for this issuer.
People & organizations
Current and past Form D appearances. These existing records do not establish a person's current role or uniquely identify them across issuers.
| Name | Reported role |
|---|---|
| Kathryn Larson | Director |
| Brandford Lu | Director |
| Cecile Vienney | Director |
Issuer details
Industry: Other Health Care (See others in industry)
Address:
C/O Orbiss Inc. 1411 Broadway, 16 Th Floor
New York, NY, 10018
New York, NY, 10018